Cargando…
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137985/ https://www.ncbi.nlm.nih.gov/pubmed/32032529 http://dx.doi.org/10.1016/S0140-6736(20)30304-4 |
| _version_ | 1783518516767358976 |
|---|---|
| author | Richardson, Peter Griffin, Ivan Tucker, Catherine Smith, Dan Oechsle, Olly Phelan, Anne Rawling, Michael Savory, Edward Stebbing, Justin |
| author_facet | Richardson, Peter Griffin, Ivan Tucker, Catherine Smith, Dan Oechsle, Olly Phelan, Anne Rawling, Michael Savory, Edward Stebbing, Justin |
| author_sort | Richardson, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7137985 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71379852020-04-08 Baricitinib as potential treatment for 2019-nCoV acute respiratory disease Richardson, Peter Griffin, Ivan Tucker, Catherine Smith, Dan Oechsle, Olly Phelan, Anne Rawling, Michael Savory, Edward Stebbing, Justin Lancet Article Elsevier Ltd. 2020 2020-02-04 /pmc/articles/PMC7137985/ /pubmed/32032529 http://dx.doi.org/10.1016/S0140-6736(20)30304-4 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Richardson, Peter Griffin, Ivan Tucker, Catherine Smith, Dan Oechsle, Olly Phelan, Anne Rawling, Michael Savory, Edward Stebbing, Justin Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title_full | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title_fullStr | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title_full_unstemmed | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title_short | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease |
| title_sort | baricitinib as potential treatment for 2019-ncov acute respiratory disease |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137985/ https://www.ncbi.nlm.nih.gov/pubmed/32032529 http://dx.doi.org/10.1016/S0140-6736(20)30304-4 |
| work_keys_str_mv | AT richardsonpeter baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT griffinivan baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT tuckercatherine baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT smithdan baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT oechsleolly baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT phelananne baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT rawlingmichael baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT savoryedward baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease AT stebbingjustin baricitinibaspotentialtreatmentfor2019ncovacuterespiratorydisease |